Acute Agitation And Aggression Treatment Market Trends 2025-2034: Growth, Strategic Insights, and Opportunities Ahead
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Industry-Specific Factors Are Fueling the Growth of theAcute Agitation And Aggression Treatment Market?
The rising incidence of dementia is expected to fuel the growth of the acute agitation and aggression treatment market. Dementia often involves symptoms such as agitation, which requires treatment to reduce harmful behaviors and enhance the quality of life. For example, in February 2023, the Australian Institute of Health and Welfare projected that the number of people in Australia with dementia would double by 2058. As dementia cases increase, the demand for treatments addressing agitation and aggression will grow.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13078&type=smp
#What Long-Term Growth Rate is Expected for theAcute Agitation And Aggression Treatment Market Between 2025 and 2034?
The acute agitation and aggression treatment market size has grown strongly in recent years. It will grow from $5.72 billion in 2024 to $6.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth can be attributed to advancements in pharmacology, a rise in clinical research, regulatory approvals, an increase in the prevalence of acute agitation and aggression cases, and heightened awareness regarding mental health.
The acute agitation and aggression treatment market is projected to grow to $7.77 billion by 2029, at a CAGR of 6.4%. The forecasted growth is driven by the aging population, increased healthcare infrastructure, rising investment in pharmaceuticals, the rise of home-based care, and increasing disposable income. Key trends include non-pharmacological interventions, precision medicine, AI and predictive analytics, community-based support, and industry collaboration.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13078
What New Market Trends Are Reshaping theAcute Agitation And Aggression Treatment Market and Its Opportunities?
In the acute agitation and aggression treatment market, companies are developing innovative products and obtaining approvals, such as IGALMI (dexmedetomidine), offering a new treatment for patients with agitation associated with schizophrenia or bipolar disorder. IGALMI (dexmedetomidine) is a sublingual film that treats acute agitation linked to schizophrenia or bipolar I or II disorder in adults. In April 2022, BioXcel Therapeutics Inc., a U.S.-based biopharmaceutical company, received FDA approval for IGALMI (dexmedetomidine), which works quickly and is short-acting, with effects lasting about two hours, offering an enhancement to current therapies for severe or life-threatening conditions.
Which Companies Are Leading the Charge in Expanding theAcute Agitation And Aggression Treatment Market Growth?
Major companies operating in the acute agitation and aggression treatment market include Pfizer Inc., Johnson and Johnson Pvt Ltd., F Hoffmann-La Roche Ltd., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, GlaxoSmithKline plc., Eli Lilly and Company, Teva Pharmaceutical Industries Ltd., Otsuka Pharmaceutical Co Ltd., Mylan NV, Biogen Inc., Bausch Health Companies Inc., UCB SA, Servier Laboratories, Sun Pharmaceutical Industries Ltd., AstraZeneca PLC, Ono Pharmaceutical Co Ltd., Apotex Inc., H Lundbeck A/S, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Neurocrine Biosciences Inc., Aurobindo Pharma Limited, Alkermes plc., Indivior plc., Sunovion Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., and Alexza Pharmaceuticals Inc
How is the Global Acute Agitation And Aggression Treatment Market Segemented?
The acute agitation and aggression treatment market covered in this report is segmented –
1) By Treatment Approach: Behavioral Approaches, Environmental Interventions, Pharmacologic Approaches
2) By Drug Class: Anti-Psychotics, Benzodiazepines, Other Drug Classes
3) By Route of Administration: Oral, Intramuscular, Other Routes of Administrations
4) By Indication: Schizophrenia, Dementia, Bipolar Disorder, Depression, Drug-Induced Agitation And Aggression, Alcohol Withdrawal, Other Indications
5) By End User: Hospitals And Ambulatory Surgical Centers, Psychiatric Care Facilities, Other End Users
Subsegments:
1) By Box Style: Standard Box Action Cameras, Modular Box Action Cameras
2) By Cube Style: Compact Cube Action Cameras, Cube Cameras with Integrated Mounts
3) By Bullet Style: Long, Cylindrical Action Cameras, Mountable Bullet Cameras
4) By Periscope & 360°: 360-Degree Cameras, Periscope Cameras
5) By Other Types: Wearable Action Cameras, Drone Action Cameras, Specialty Action Cameras
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=13078&type=smp
Which Geographics are Influencing the Growth of the Acute Agitation And Aggression Treatment Market?
The countries covered in the acute agitation and aggression treatment market market report include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.
Browse Through More Reports Similar to the Global Acute Agitation And Aggression Treatment Market 2025, By The Business Research Company:
Neurodegenerative Disorder Therapeutics Global Market Report 2024
Neuroscience Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neuroscience-global-market-report
Neurostimulation Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/neurostimulation-devices-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
